JP2014094951A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014094951A5 JP2014094951A5 JP2014000319A JP2014000319A JP2014094951A5 JP 2014094951 A5 JP2014094951 A5 JP 2014094951A5 JP 2014000319 A JP2014000319 A JP 2014000319A JP 2014000319 A JP2014000319 A JP 2014000319A JP 2014094951 A5 JP2014094951 A5 JP 2014094951A5
- Authority
- JP
- Japan
- Prior art keywords
- neuregulin
- functional fragment
- effective amount
- neuregulin protein
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000014413 Neuregulin Human genes 0.000 claims 16
- 108050003475 Neuregulin Proteins 0.000 claims 16
- 239000012634 fragment Substances 0.000 claims 11
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 238000011282 treatment Methods 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 230000000069 prophylactic effect Effects 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 230000003111 delayed effect Effects 0.000 claims 3
- 208000010125 myocardial infarction Diseases 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 206010047470 viral myocarditis Diseases 0.000 claims 3
- 208000031229 Cardiomyopathies Diseases 0.000 claims 2
- 206010048610 Cardiotoxicity Diseases 0.000 claims 2
- 231100000259 cardiotoxicity Toxicity 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000007681 cardiovascular toxicity Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2002/000349 WO2003099320A1 (en) | 2002-05-24 | 2002-05-24 | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
| CNPCT/CN02/00349 | 2002-05-24 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010223952A Division JP5809789B2 (ja) | 2002-05-24 | 2010-10-01 | 薬学的組成物、およびキット |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016018132A Division JP6603149B2 (ja) | 2002-05-24 | 2016-02-02 | 心血管疾患を処置するためのニューレギュリン法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014094951A JP2014094951A (ja) | 2014-05-22 |
| JP2014094951A5 true JP2014094951A5 (enExample) | 2014-07-03 |
| JP5964868B2 JP5964868B2 (ja) | 2016-08-03 |
Family
ID=29555543
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004506824A Pending JP2005532332A (ja) | 2002-05-24 | 2003-05-15 | 心血管疾患を処置するためのニューレギュリン法および組成物 |
| JP2010223952A Expired - Lifetime JP5809789B2 (ja) | 2002-05-24 | 2010-10-01 | 薬学的組成物、およびキット |
| JP2014000319A Expired - Lifetime JP5964868B2 (ja) | 2002-05-24 | 2014-01-06 | 心血管疾患を処置するためのニューレギュリン法および組成物 |
| JP2016018132A Expired - Lifetime JP6603149B2 (ja) | 2002-05-24 | 2016-02-02 | 心血管疾患を処置するためのニューレギュリン法および組成物 |
| JP2017214721A Pending JP2018052957A (ja) | 2002-05-24 | 2017-11-07 | 心血管疾患を処置するためのニューレギュリン法および組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004506824A Pending JP2005532332A (ja) | 2002-05-24 | 2003-05-15 | 心血管疾患を処置するためのニューレギュリン法および組成物 |
| JP2010223952A Expired - Lifetime JP5809789B2 (ja) | 2002-05-24 | 2010-10-01 | 薬学的組成物、およびキット |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016018132A Expired - Lifetime JP6603149B2 (ja) | 2002-05-24 | 2016-02-02 | 心血管疾患を処置するためのニューレギュリン法および組成物 |
| JP2017214721A Pending JP2018052957A (ja) | 2002-05-24 | 2017-11-07 | 心血管疾患を処置するためのニューレギュリン法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US7795212B2 (enExample) |
| EP (2) | EP2606901A1 (enExample) |
| JP (5) | JP2005532332A (enExample) |
| CN (4) | CN100522997C (enExample) |
| AU (3) | AU2002304965A1 (enExample) |
| CA (1) | CA2487112C (enExample) |
| ES (1) | ES2627547T3 (enExample) |
| WO (3) | WO2003099320A1 (enExample) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP785098A0 (en) * | 1998-12-21 | 1999-01-21 | Victor Chang Cardiac Research Institute, The | Treatment of heart disease |
| US8246671B2 (en) | 1999-08-09 | 2012-08-21 | Cardiokinetix, Inc. | Retrievable cardiac devices |
| US10307147B2 (en) | 1999-08-09 | 2019-06-04 | Edwards Lifesciences Corporation | System for improving cardiac function by sealing a partitioning membrane within a ventricle |
| US7674222B2 (en) | 1999-08-09 | 2010-03-09 | Cardiokinetix, Inc. | Cardiac device and methods of use thereof |
| US9694121B2 (en) | 1999-08-09 | 2017-07-04 | Cardiokinetix, Inc. | Systems and methods for improving cardiac function |
| US8529430B2 (en) | 2002-08-01 | 2013-09-10 | Cardiokinetix, Inc. | Therapeutic methods and devices following myocardial infarction |
| US8257428B2 (en) | 1999-08-09 | 2012-09-04 | Cardiokinetix, Inc. | System for improving cardiac function |
| US8377114B2 (en) | 1999-08-09 | 2013-02-19 | Cardiokinetix, Inc. | Sealing and filling ventricular partitioning devices to improve cardiac function |
| US9332992B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Method for making a laminar ventricular partitioning device |
| US10064696B2 (en) | 2000-08-09 | 2018-09-04 | Edwards Lifesciences Corporation | Devices and methods for delivering an endocardial device |
| US9332993B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
| US9078660B2 (en) | 2000-08-09 | 2015-07-14 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
| WO2003099320A1 (en) | 2002-05-24 | 2003-12-04 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
| AU2003237367A1 (en) * | 2002-06-03 | 2003-12-19 | Chiron Corporation | Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer |
| JP2009503105A (ja) * | 2005-08-03 | 2009-01-29 | イミュノジェン・インコーポレーテッド | 免疫複合体製剤 |
| WO2007028085A2 (en) * | 2005-09-02 | 2007-03-08 | Morehouse School Of Medicine | Neuregulin for prevention and treatment of damage from acute assault on vascular and neuronal tissues |
| US20070213264A1 (en) | 2005-12-02 | 2007-09-13 | Mingdong Zhou | Neuregulin variants and methods of screening and using thereof |
| AU2006332340B2 (en) | 2005-12-30 | 2013-09-26 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Extended release of neuregulin for improved cardiac function |
| WO2007130724A2 (en) | 2006-02-06 | 2007-11-15 | Northwind Ventures | Systems and methods for volume reduction |
| US8628929B2 (en) | 2007-05-10 | 2014-01-14 | Acorda Therapeutics, Inc. | Methods for detecting cardiac damage |
| CN101310766B (zh) * | 2007-05-25 | 2014-04-16 | 上海泽生科技开发有限公司 | 神经调节蛋白的新用途 |
| CN103432681A (zh) * | 2007-05-25 | 2013-12-11 | 上海泽生科技开发有限公司 | 包含神经调节蛋白的药物制剂及装置 |
| CN101310765A (zh) * | 2007-05-25 | 2008-11-26 | 上海泽生科技开发有限公司 | 神经调节蛋白应用于人的安全剂量 |
| US20090156488A1 (en) | 2007-09-12 | 2009-06-18 | Zensun (Shanghai) Science & Technology Limited | Use of neuregulin for organ preservation |
| JP5797112B2 (ja) * | 2008-07-17 | 2015-10-21 | アコーダ セラピューティクス インコーポレイテッド | 心不全の治療または予防のためのニューレグリンまたはそのサブ配列の治療的投与方法 |
| ES2609927T3 (es) * | 2008-08-15 | 2017-04-25 | Acorda Therapeutics, Inc. | Composiciones y métodos para tratamientos durante periodos no agudos después de lesiones neurológicas del SNC |
| WO2010033249A2 (en) | 2008-09-22 | 2010-03-25 | Massachusetts Institute Of Technology | Compositions of and methods using ligand dimers |
| EP2808339B1 (en) | 2008-11-28 | 2017-02-15 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Neuregulin peptides and their use |
| US20110229444A1 (en) * | 2008-11-28 | 2011-09-22 | Zensun (Shanghai) Science & Technology Limited | Neuregulin And Cardiac Stem Cells |
| ES2748886T3 (es) * | 2009-06-09 | 2020-03-18 | Zensun Shanghai Science & Tech Co Ltd | Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca |
| EP2440236B1 (en) * | 2009-06-09 | 2016-05-04 | Zensun (Shanghai) Science and Technology Limited | Neuregulin based methods for treating heart failure |
| EP2493495A4 (en) * | 2009-07-10 | 2013-08-21 | Univ Northwestern | HERZSCHÜTZENDE ROLE OF LIVER CELLS AND SEKRETORIC FACTORS FROM LIVER CELLS IN MYOCARDIAN EMERGENCE |
| US20120121557A1 (en) * | 2009-07-22 | 2012-05-17 | Children's Medical Center Corporation | Neuregulin induced proliferation of cardiomyocytes |
| JP6096262B2 (ja) * | 2009-08-25 | 2017-03-15 | ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． | ニューレグリンに基づく心不全の治療方法 |
| GB2487339A (en) * | 2009-10-23 | 2012-07-18 | Amorcyte Inc | Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency |
| CA2777495A1 (en) | 2009-10-26 | 2011-05-12 | Cardiokinetix, Inc. | Ventricular volume reduction |
| CN103772498B (zh) * | 2009-11-09 | 2015-07-15 | 上海泽生科技开发有限公司 | 纽兰格林及其用途 |
| CN102139095A (zh) | 2010-01-29 | 2011-08-03 | 上海泽生科技开发有限公司 | 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物 |
| WO2011119836A1 (en) * | 2010-03-24 | 2011-09-29 | Massachusetts Institute Of Technology | Methods and compositions for cardioprotection and cardioregeneration |
| CN104399062A (zh) * | 2011-01-11 | 2015-03-11 | 上海泽生科技开发有限公司 | 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物 |
| MY181093A (en) | 2011-03-02 | 2020-12-17 | Berg Llc | Interrogatory cell-based assays and uses thereof |
| US8754044B2 (en) | 2011-05-03 | 2014-06-17 | Northwestern University | Neuroprotection by hepatic cells and hepatocyte secretory factors |
| WO2013053076A1 (en) | 2011-10-10 | 2013-04-18 | Zensun （Shanghai）Science & Technology Limited | Compositions and methods for treating heart failure |
| AU2012376214B2 (en) | 2012-04-02 | 2019-02-14 | Berg Llc | Interrogatory cell-based assays and uses thereof |
| SG11201407569PA (en) | 2012-05-22 | 2014-12-30 | Berg Llc | Interrogatory cell-based assays for identifying drug-induced toxicity markers |
| NZ706155A (en) | 2012-09-12 | 2018-09-28 | Berg Llc | Use of markers in the identification of cardiotoxic agents |
| WO2014051567A1 (en) * | 2012-09-26 | 2014-04-03 | Morehouse School Of Medicine | Chimeric neuregulins and method of making and use thereof |
| CN109276705B (zh) | 2012-10-08 | 2023-10-20 | 上海泽生科技开发股份有限公司 | 治疗糖尿病患者心力衰竭的组份和方法 |
| EP3610905B1 (en) | 2013-05-22 | 2021-03-31 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Extended release of neuregulin for treating heart failure |
| ES2993142T3 (en) * | 2013-10-01 | 2024-12-23 | Kymab Ltd | Animal models and therapeutic molecules |
| CA2926382C (en) | 2013-10-18 | 2020-06-02 | Attoquant Diagnostics Gmbh | Method for diagnosis of primary hyperaldosteronism |
| CN110946993A (zh) | 2014-01-03 | 2020-04-03 | 上海泽生科技开发股份有限公司 | 纽兰格林制剂的配方 |
| CN106535921A (zh) | 2014-04-15 | 2017-03-22 | 安特卫普大学 | 肾病的治疗 |
| CN114203296B (zh) | 2014-09-11 | 2025-10-17 | 布普格生物制药公司 | 基于患者数据的用于健康护理诊断和治疗的贝叶斯因果关系网络模型 |
| CN105497876B (zh) | 2014-09-24 | 2021-01-15 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物 |
| CA2962747C (en) | 2014-09-28 | 2023-02-28 | Cardiokinetix, Inc. | Apparatuses for treating cardiac dysfunction |
| CN111407882A (zh) * | 2014-10-17 | 2020-07-14 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物 |
| EP3247380A1 (en) * | 2015-01-20 | 2017-11-29 | Universiteit Antwerpen | Neuregulin in the treatment of fibrotic disorders |
| CN104922153A (zh) * | 2015-04-02 | 2015-09-23 | 连祺周 | Nrg1-erbb4复合体在制备治疗心肌缺血的药物中的应用 |
| US10017574B2 (en) * | 2015-05-07 | 2018-07-10 | Yeda Research And Development Co. Ltd. | Methods, kits and devices for promoting cardiac regeneration |
| US10758560B2 (en) | 2015-12-22 | 2020-09-01 | Societe Des Produits Nestle S.A. | Methods for treating sarcopenia and frailty |
| US10898330B2 (en) | 2017-03-28 | 2021-01-26 | Edwards Lifesciences Corporation | Positioning, deploying, and retrieving implantable devices |
| EP3774859B1 (en) * | 2018-04-11 | 2024-03-13 | Salubris Biotherapeutics, Inc. | Human neuregulin-1 (nrg-1) recombinant fusion protein compositions and methods of use thereof |
| CN111407881A (zh) * | 2019-01-07 | 2020-07-14 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延迟心肌损伤的方法和组合物 |
| AR121035A1 (es) * | 2019-04-01 | 2022-04-13 | Lilly Co Eli | Compuestos de neuregulina-4 y métodos de uso |
| CN109999015A (zh) * | 2019-04-24 | 2019-07-12 | 江苏省中医药研究院 | 紫草素在制备预防或治疗房颤药物中的用途 |
| CA3157354A1 (en) | 2019-09-16 | 2021-03-25 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Recombinant human neuregulin derivatives and use thereof |
| CN110714068A (zh) * | 2019-11-14 | 2020-01-21 | 南通大学 | 膜蛋白分子ErbB4在制备治疗脑缺血损伤药物中的应用 |
| CN113289002A (zh) | 2020-02-24 | 2021-08-24 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物 |
| CN113238060B (zh) * | 2021-05-08 | 2022-10-11 | 迈克生物股份有限公司 | 用于预测或诊断心肌炎的试剂盒 |
| WO2023070078A1 (en) * | 2021-10-22 | 2023-04-27 | The Research Institute At Nationwide Children's Hospital | Neuregulin for protection against respiratory viral infection and post-viral disease |
Family Cites Families (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| EP0052322B1 (de) | 1980-11-10 | 1985-03-27 | Gersonde, Klaus, Prof. Dr. | Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| DE3377363D1 (en) | 1982-03-31 | 1988-08-18 | Ajinomoto Kk | Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| DE3220116A1 (de) | 1982-05-28 | 1983-12-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| JPS607934A (ja) | 1983-06-29 | 1985-01-16 | Dai Ichi Seiyaku Co Ltd | リポソ−ムの製造方法 |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| ATE159858T1 (de) | 1983-09-26 | 1997-11-15 | Ehrenfeld Udo | Mittel und erzeugnis für die diagnose und therapie von tumoren sowie zur behandlung von schwächen der zelligen und humoralen immunabwehr |
| DE3474511D1 (en) | 1983-11-01 | 1988-11-17 | Terumo Corp | Pharmaceutical composition containing urokinase |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| US4569790A (en) | 1984-03-28 | 1986-02-11 | Cetus Corporation | Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| WO1989001489A1 (en) | 1987-08-10 | 1989-02-23 | Commonwealth Scientific And Industrial Research Or | Control of angiogenesis and compositions and methods therefor |
| SE463851B (sv) | 1988-09-02 | 1991-02-04 | Amsu Ltd | Komposition foer behandling av erektil dysfunktion via uretra |
| JPH02226533A (ja) | 1989-02-27 | 1990-09-10 | Mitsubishi Electric Corp | 情報記録媒体 |
| US5716930A (en) | 1991-04-10 | 1998-02-10 | Ludwig Institute For Cancer Research | Glial growth factors |
| GB9107566D0 (en) | 1991-04-10 | 1991-05-29 | Ludwig Inst Cancer Res | Glial mitogenic factors,their preparation and use |
| US5530109A (en) | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
| US7115554B1 (en) | 1993-05-06 | 2006-10-03 | Acorda Therapeutics, Inc. | Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| IL101943A0 (en) | 1991-05-24 | 1992-12-30 | Genentech Inc | Structure,production and use of heregulin |
| US5367060A (en) | 1991-05-24 | 1994-11-22 | Genentech, Inc. | Structure, production and use of heregulin |
| US5834229A (en) | 1991-05-24 | 1998-11-10 | Genentech, Inc. | Nucleic acids vectors and host cells encoding and expressing heregulin 2-α |
| EP0625991B1 (en) | 1992-02-10 | 1999-04-28 | Interferon Sciences, Inc. | Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
| US6087323A (en) | 1992-04-03 | 2000-07-11 | Cambridge Neuroscience, Inc. | Use of neuregulins as modulators of cellular communication |
| DE4221256C2 (de) | 1992-06-26 | 1997-07-10 | Lancaster Group Ag | Galenische Zusammensetzung für die topische Anwendung |
| US5869305A (en) | 1992-12-04 | 1999-02-09 | The University Of Pittsburgh | Recombinant viral vector system |
| EP0647449A1 (en) | 1993-06-24 | 1995-04-12 | Takeda Chemical Industries, Ltd. | Sustained-release preparation of anti-endothelin substance |
| US5834441A (en) | 1993-09-13 | 1998-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral (AAV) liposomes and methods related thereto |
| US5399699A (en) | 1994-01-24 | 1995-03-21 | Abbott Laboratories | Indole iminooxy derivatives which inhibit leukotriene biosynthesis |
| DE69522492T2 (de) | 1994-04-09 | 2002-05-23 | F. Hoffmann-La Roche Ag, Basel | Verfahren zur Herstellung von Alpha-Interferon |
| US5770567A (en) | 1994-11-14 | 1998-06-23 | Genentech, Inc. | Sensory and motor neuron derived factor (SMDF) |
| ES2225874T3 (es) | 1995-03-10 | 2005-03-16 | Genentech, Inc. | Activacion de receptor mediante gas. |
| US6750196B1 (en) | 1995-03-27 | 2004-06-15 | Acorda Therapeutics | Methods of treating disorders of the eye |
| US5741511A (en) | 1995-04-12 | 1998-04-21 | Sam Yang Co., Ltd. | Transdermal drug delivery device for treating erectile dysfunction |
| US6033660A (en) | 1995-05-10 | 2000-03-07 | Genentech, Inc. | Method of treating a nervous system injury with cultured schwann cells |
| US5721139A (en) | 1995-05-10 | 1998-02-24 | Genentech, Inc. | Isolating and culturing schwann cells |
| US5714385A (en) | 1995-05-10 | 1998-02-03 | Genentech, Inc. | Media for culturing schwann cells |
| US5912326A (en) | 1995-09-08 | 1999-06-15 | President And Fellows Of Harvard College | Cerebellum-derived growth factors |
| US5888767A (en) | 1996-11-27 | 1999-03-30 | The Johns Hopkins University School Of Medicine | Method of using a conditionally replicating viral vector to express a gene |
| JP2000502682A (ja) | 1995-12-22 | 2000-03-07 | ローカルメッド インコーポレイテッド | 血管新生を促進する成長因子の局所的血管内デリバリー |
| US5736154A (en) | 1996-03-11 | 1998-04-07 | Fuisz Technologies Ltd. | Transdermal delivery system |
| US5968511A (en) | 1996-03-27 | 1999-10-19 | Genentech, Inc. | ErbB3 antibodies |
| US5834235A (en) | 1996-06-21 | 1998-11-10 | Health Research, Incorporated | Inferferon-α-induced protein |
| EP0912734B1 (en) | 1996-07-12 | 2010-11-03 | Genentech, Inc. | Chimeric heteromultimer adhesins |
| WO1998002541A1 (en) | 1996-07-12 | 1998-01-22 | Genentech, Inc. | Gamma-heregulin |
| US6593290B1 (en) | 1996-11-01 | 2003-07-15 | Genentech, Inc. | Treatment of inner ear hair cells |
| US6156728A (en) | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
| US20020002276A1 (en) | 1997-02-10 | 2002-01-03 | Genentech, Inc. | Chimeric heteromultimer adhesins |
| CA2278151C (en) | 1997-02-10 | 2010-11-16 | Genentech, Inc. | Heregulin variants |
| US6136558A (en) * | 1997-02-10 | 2000-10-24 | Genentech, Inc. | Heregulin variants |
| WO1998055611A1 (en) | 1997-06-06 | 1998-12-10 | Regents Of The University Of Michigan | Neuregulin response element and uses therefor |
| US6121415A (en) | 1997-07-09 | 2000-09-19 | Genentech, Inc. | ErbB4 receptor-specific neuregolin related ligands and uses therefor |
| SE9703226D0 (sv) | 1997-09-08 | 1997-09-08 | Astra Ab | New pharmaceutical composition |
| WO1999018976A1 (en) | 1997-10-14 | 1999-04-22 | Cambridge Neuroscience, Inc. | Therapeutic methods comprising use of a neuregulin |
| US6197801B1 (en) | 1998-01-14 | 2001-03-06 | Usa Doctors Products, Inc. | Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| US5962274A (en) | 1998-03-13 | 1999-10-05 | Wake Forest University | Viral vector directed to predetermined target cells |
| AUPP785098A0 (en) * | 1998-12-21 | 1999-01-21 | Victor Chang Cardiac Research Institute, The | Treatment of heart disease |
| US6446242B1 (en) | 1999-04-02 | 2002-09-03 | Actel Corporation | Method and apparatus for storing a validation number in a field-programmable gate array |
| US6635249B1 (en) * | 1999-04-23 | 2003-10-21 | Cenes Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
| US6933122B1 (en) | 1999-05-14 | 2005-08-23 | The Trustees Of Columbia University In The City Of New York | A-form of cytoplasmic domain of nARIA (CRD-neuregulin) and uses thereof |
| CN1138785C (zh) * | 1999-06-04 | 2004-02-18 | 周明东 | 生长因子神经调节蛋白及其类似物的新应用 |
| US6602851B1 (en) | 1999-10-08 | 2003-08-05 | Uab Research Foundation | SMDF and GGF neuregulin splice variant isoforms and uses thereof |
| US6811788B2 (en) | 2000-01-19 | 2004-11-02 | Baofa Yu | Combinations and methods for treating neoplasms |
| ES2252216T3 (es) | 2000-02-11 | 2006-05-16 | Proteosys Ag | Utilizacion de neorregulina-beta como indicador y/o diana. |
| AU2001241838A1 (en) | 2000-02-28 | 2001-09-12 | Decode Genetics Ehf | Human schizophrenia gene |
| CA2400595A1 (en) * | 2000-02-28 | 2001-09-07 | Decode Genetics Ehf | Human schizophrenia gene |
| US6544759B1 (en) | 2000-04-21 | 2003-04-08 | Yeda Research And Development Co. Ltd | Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| WO2003099320A1 (en) | 2002-05-24 | 2003-12-04 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
| CN1498656A (zh) | 2002-11-08 | 2004-05-26 | 上海泽生科技开发有限公司 | 神经调节蛋白用于心肌梗死治疗的方法和组合物 |
| JP2004348674A (ja) * | 2003-05-26 | 2004-12-09 | Noritsu Koki Co Ltd | 領域検出方法及びその装置 |
| CN1715926B (zh) | 2004-07-02 | 2011-08-17 | 上海泽生科技开发有限公司 | 神经调节蛋白突变体的应用 |
| CN1743006A (zh) | 2004-09-02 | 2006-03-08 | 上海泽生科技开发有限公司 | Mapk抑制剂的新用途及组合物 |
| CN1743005A (zh) | 2004-09-02 | 2006-03-08 | 上海泽生科技开发有限公司 | Pi3－k抑制剂的新用途及组合物 |
| US20070213264A1 (en) | 2005-12-02 | 2007-09-13 | Mingdong Zhou | Neuregulin variants and methods of screening and using thereof |
| AU2006332340B2 (en) | 2005-12-30 | 2013-09-26 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Extended release of neuregulin for improved cardiac function |
| US9580515B2 (en) | 2006-08-21 | 2017-02-28 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Neukinase, a downstream protein of neuregulin |
| US20090156488A1 (en) | 2007-09-12 | 2009-06-18 | Zensun (Shanghai) Science & Technology Limited | Use of neuregulin for organ preservation |
-
2002
- 2002-05-24 WO PCT/CN2002/000349 patent/WO2003099320A1/en not_active Ceased
- 2002-05-24 AU AU2002304965A patent/AU2002304965A1/en not_active Abandoned
- 2002-09-18 WO PCT/CN2002/000664 patent/WO2003099321A1/en not_active Ceased
- 2002-09-18 AU AU2002336030A patent/AU2002336030A1/en not_active Abandoned
-
2003
- 2003-05-15 CN CNB038118661A patent/CN100522997C/zh not_active Expired - Lifetime
- 2003-05-15 EP EP12194239.5A patent/EP2606901A1/en not_active Withdrawn
- 2003-05-15 AU AU2003238336A patent/AU2003238336B2/en not_active Expired
- 2003-05-15 CA CA2487112A patent/CA2487112C/en not_active Expired - Fee Related
- 2003-05-15 WO PCT/CN2003/000355 patent/WO2003099300A1/en not_active Ceased
- 2003-05-15 CN CN2009101185220A patent/CN101491670B/zh not_active Expired - Lifetime
- 2003-05-15 EP EP03732172.6A patent/EP1553960B1/en not_active Expired - Lifetime
- 2003-05-15 CN CNA200610139361XA patent/CN101007027A/zh active Pending
- 2003-05-15 ES ES03732172.6T patent/ES2627547T3/es not_active Expired - Lifetime
- 2003-05-15 JP JP2004506824A patent/JP2005532332A/ja active Pending
- 2003-05-15 CN CN2006101543547A patent/CN1935254B/zh not_active Expired - Lifetime
-
2004
- 2004-11-24 US US10/997,167 patent/US7795212B2/en not_active Expired - Lifetime
-
2010
- 2010-09-10 US US12/879,023 patent/US8785387B2/en not_active Expired - Lifetime
- 2010-10-01 JP JP2010223952A patent/JP5809789B2/ja not_active Expired - Lifetime
-
2014
- 2014-01-06 JP JP2014000319A patent/JP5964868B2/ja not_active Expired - Lifetime
- 2014-05-06 US US14/271,198 patent/US9555076B2/en not_active Expired - Fee Related
-
2016
- 2016-02-02 JP JP2016018132A patent/JP6603149B2/ja not_active Expired - Lifetime
-
2017
- 2017-01-30 US US15/419,946 patent/US20170360889A1/en not_active Abandoned
- 2017-11-07 JP JP2017214721A patent/JP2018052957A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014094951A5 (enExample) | ||
| IL285782A (en) | Compounds, compositions, and methods for treating disease | |
| JP2016041733A5 (enExample) | ||
| IL263425A (en) | Antagonistic t-linked antibodies to human tgfb2, tgfb1 and tgfb3 and their use for the treatment of pulmonary fibrosis | |
| PH12018500573A1 (en) | Hepatitis b core protein modulators | |
| IL290792A (en) | Preparations and methods for treating viral infections | |
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| MX2016009975A (es) | Derivados de dihidropteridinona y sus usos. | |
| JP2014051497A5 (enExample) | ||
| PH12018550026A1 (en) | Acetamide thienotriazoldiazepines and uses thereof | |
| WO2017044849A8 (en) | Cyano thienotriazolodiazepines and uses thereof | |
| EA201791903A1 (ru) | β-D-2'-ДЕЗОКСИ-2'-α-ФТОР-2'-β-C-ЗАМЕЩЕННЫЕ-2-МОДИФИЦИРОВАННЫЕ-N6-ЗАМЕЩЕННЫЕ ПУРИНОВЫЕ НУКЛЕОТИДЫ ДЛЯ ЛЕЧЕНИЯ ВЫЗВАННЫХ HCV ЗАБОЛЕВАНИЙ | |
| JP2016116527A5 (enExample) | ||
| WO2016022970A8 (en) | Dihydropteridinone derivatives and uses thereof | |
| HK1254432A1 (zh) | 用於治疗纤维性疾病的方法和组合物 | |
| WO2017029558A3 (en) | Methods for improving health of farmed fish | |
| WO2016142708A3 (en) | Pharmaceutical composition | |
| EA202190429A1 (ru) | Биодоступные пероральные дозированные формы | |
| JP2016522188A5 (enExample) | ||
| MY184269A (en) | Broad-spectrum anti-influenza virus therapeutic peptides | |
| JP2016160183A5 (ja) | 筋萎縮抑制剤及び筋萎縮抑制用飲食品 | |
| MX2016010482A (es) | Combinaciones farmaceuticas que comprenden un inhibidor de pi3k para el tratamiento de cancer. | |
| JP2018043942A5 (enExample) | ||
| WO2018024888A8 (en) | Compositions and the use thereof for treating or preventing rosacea | |
| WO2016054365A8 (en) | Pharmaceutical composition comprising aspirin, metformin, and serotonin with non-ionic surfactant |